Intelligent Bio Solutions Inc. (INBS)
NASDAQ: INBS · Real-Time Price · USD
1.610
-0.040 (-2.42%)
Sep 29, 2026, 2:07 PM EDT - Market open
Intelligent Bio Solutions Revenue
In the fiscal year ending June 30, 2026, Intelligent Bio Solutions had annual revenue of $4.22M with 38.09% growth. Intelligent Bio Solutions had revenue of $1.15M in the quarter ending June 30, 2026, with 35.78% growth.
Revenue (ttm)
$4.22M
Revenue Growth
+38.09%
P/S Ratio
1.19
Revenue / Employee
$70,253
Employees
60
Market Cap
4.87M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2026 | 4.22M | 1.16M | 38.09% |
| Jun 30, 2025 | 3.05M | -59.25K | -1.90% |
| Jun 30, 2024 | 3.11M | 1.85M | 147.58% |
| Jun 30, 2023 | 1.26M | 819.73K | 187.52% |
| Jun 30, 2022 | 437.15K | -1.54M | -77.93% |
| Jun 30, 2021 | 1.98M | 1.79M | 949.30% |
| Jun 30, 2020 | 188.74K | - | - |
| Jun 30, 2019 | - | - | - |
| Jun 30, 2018 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Trinity Biotech | 43.79M |
| WORK Medical Technology Group LTD | 10.72M |
| INVO Fertility | 7.53M |
| 20/20 Biolabs | 2.04M |
| Co-Diagnostics | 721.39K |
| Adagio Medical Holdings | 137.00K |
| Phaos Technology Holdings (Cayman) Limited | 103.68K |
INBS News
- 4 days ago - Intelligent Bio Solutions Transcript: Fireside chat - Transcripts
- 14 days ago - Intelligent Bio Solutions Registration statement: Registration filing - Filings
- 19 days ago - Intelligent Bio Solutions to Host Virtual Fireside Chat on September 24th at 4:30 p.m. ET - GlobeNewsWire
- 20 days ago - Intelligent Bio Solutions submits 510 premarket notification to FDA - TheFly
- 20 days ago - Intelligent Bio Solutions Submits FDA 510(k) Package for Intelligent Fingerprinting Drug Screening System, Seeking U.S. Market Clearance - GlobeNewsWire
- 4 weeks ago - Intelligent Bio Solutions announces private placement of up to $15M - TheFly
- 4 weeks ago - Intelligent Bio Solutions Achieves Above 98% Accuracy in Method Comparison Study, Supporting Planned 2026 FDA 510(k) Submission - GlobeNewsWire
- 4 weeks ago - Intelligent Bio Solutions Announces Private Placement of up to $15 Million to a Single Existing Institutional Investor Priced At-the-Market Under Nasdaq Rules - GlobeNewsWire